Impact of CYP2C8*3 polymorphism on in vitro metabolism of imatinib to N-desmethyl imatinib.
about
CYP2C8 Genotype Significantly Alters Imatinib Metabolism in Chronic Myeloid Leukaemia Patients.Kinase inhibitor pharmacokinetics: comprehensive summary and roadmap for addressing inter-individual variability in exposure.Pharmacokinetic drug-drug interactions of tyrosine kinase inhibitors: A focus on cytochrome P450, transporters, and acid suppression therapy.
P2860
Impact of CYP2C8*3 polymorphism on in vitro metabolism of imatinib to N-desmethyl imatinib.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Impact of CYP2C8*3 polymorphis ...... tinib to N-desmethyl imatinib.
@en
type
label
Impact of CYP2C8*3 polymorphis ...... tinib to N-desmethyl imatinib.
@en
prefLabel
Impact of CYP2C8*3 polymorphis ...... tinib to N-desmethyl imatinib.
@en
P2860
P1433
P1476
Impact of CYP2C8*3 polymorphis ...... tinib to N-desmethyl imatinib.
@en
P2093
Andrew A Somogyi
Muhammad Suleman Khan
P2860
P304
P356
10.3109/00498254.2015.1060649
P407
P577
2015-07-10T00:00:00Z